Hemodiaz Life Sciences Private Limited - Company Profile

It is a healthcare private limited company based in New Delhi, Delhi, India, established in 1998.
1998 New Delhi, Delhi, India Active
Last Updated:
Access Report
About Hemodiaz Life Sciences Private Limited

Hemodiaz Life Sciences Private Limited, a active private limited company, was established on 24 July 1998 in New Delhi, Delhi, India. Engaging in medical equipment retail & distribution within the trade sector, it holds CIN: U33111DL1998PTC095173. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹1.50 Cr and a paid-up capital of ₹1.06 Cr.

Formerly known as Shri Behari Lal Polymers Private Limited., Shri Behari Lal Polymers Private Limited. It upholds a compliant status. Employing 1 professional, Its leadership includes Vipin Dhawan (Director), Ishita Dhawan (Director), Shilpa Kapoor (Director). Past directors included Ashish Dhawan, Vipin Dhawan, Rajni Dhawan. It holds ₹15.53 Cr open charges and ₹6.79 Cr settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at Plot No. 324, Shiv Vihar West (Behind Sai Baba Mandr), Vikas Nagar, New Delhi, Delhi, 110059.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U33111DL1998PTC095173

  • Registration Number

    095173

  • Incorporation Date

    24 July 1998

  • Authorized Capital

    ₹1.50 Cr

  • Paid-Up Capital

    ₹1.06 Cr

  • ROC Code

    Roc Delhi

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 1.50 Cr
  • Paid Up Capital ₹ 1.06 Cr
  • Company Age 27 Year, 7 Months
  • Last Filing with ROC 31 Mar 2025
  • Open Charges ₹ 15.53 Cr
  • Satisfied Charges ₹ 6.79 Cr
  • Revenue Growth **** -56.42%
  • Profit Growth **** -40.90%
  • Ebitda **** 4.61%
  • Net Worth 10.57%
  • Total Assets -0.81%
Company report

Hemodiaz Life Sciences Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Hemodiaz Life Sciences Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Hemodiaz Life Sciences Private Limited?
Current Directors
Name Designation Appointment Date Status
Vipin Dhawan Director 30 May 2025 Current
Ishita Dhawan Director 10 Sep 2025 Current
Shilpa Kapoor Director 08 Aug 2025 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Additional Director 29 Sep 2012 Past
Pramod Abcsdd Director 27 Dec 2011 Past
Pramod Abcsdd Director - Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Hemodiaz Life Sciences.

Hemodiaz Life Sciences Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 56.42% decrease. The company also saw a substantial fall in profitability, with a 40.9% decrease in profit. The company's net worth Soared by an impressive increase of 10.57%.

Hemodiaz Life Sciences revenue growth over time
Hemodiaz Life Sciences profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 -56.42%
*******
*******
*******
*******
Revenue from Operations
*******
 -56.44%
*******
*******
*******
*******
Total Assets
*******
 -0.81%
*******
*******
*******
*******
Profit or Loss
*******
 -40.90%
*******
*******
*******
*******
Net Worth
*******
 10.57%
*******
*******
*******
*******
EBITDA
*******
 4.61%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Hemodiaz Life Sciences?

Unlock access to Hemodiaz Life Sciences's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹155,327,000.00

Satisfied Charges

₹67,900,000.00

Charges Breakdown by Lending Institutions
  • Others : 15.53 Cr
Latest Charge Details
Date Lender Amount Status
26 Oct 2021 Others ₹7.60 M Open
27 Apr 2021 Others ₹2.73 M Open
14 Jul 2012 Others ₹14.50 Cr Open
17 Jul 2020 Others ₹1.54 Cr Satisfied
13 Apr 2020 Others ₹8.00 M Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Hemodiaz Life Sciences?

Hemodiaz Life Sciences has a workforce of 1 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Hemodiaz Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Hemodiaz Life Sciences's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Hemodiaz Life Sciences
Recent Activity within the Organization
  • Annual General Meeting

    Progress on Hemodiaz Life Sciences Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was documented.

  • Director Appointment

    The activity Ishita Dhawan was appointed as a Director was appointed as a Director on 10 Sep 2025 & has been associated with this company since 5 months 16 days . was completed.

  • Director Appointment

    Shilpa Kapoor was appointed as a Director was appointed as a Director on 08 Aug 2025 & has been associated with this company since 6 months 19 days . was recorded as a recent event.

  • Charges

    A charge registered on 17 Jul 2020 via Charge ID 100350962 with Others was fully satisfied on 22 Jul 2025. was recorded as a recent event.

  • Charges

    Progress on A charge registered on 13 Apr 2020 via Charge ID 100333508 with Others was fully satisfied on 22 Jul 2025. was documented.

  • Charges

    A charge registered on 14 Jul 2012 via Charge ID 10371882 with Others was fully satisfied on 22 Jul 2025. was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Hemodiaz Life Sciences Private Limited?

The CIN of Hemodiaz Life Sciences Private Limited is U33111DL1998PTC095173.

Where is Hemodiaz Life Sciences Private Limited headquartered?

Hemodiaz Life Sciences Private Limited is headquartered at Plot No. 324, Shiv Vihar West (Behind Sai Baba Mandr), Vikas Nagar, New Delhi, Delhi, 110059.

When was Hemodiaz Life Sciences Private Limited incorporated?

Hemodiaz Life Sciences Private Limited was incorporated on 24 July 1998.

Who are the current directors of Hemodiaz Life Sciences Private Limited?

The current directors of Hemodiaz Life Sciences Private Limited are

What is the primary industry of Hemodiaz Life Sciences Private Limited?

The primary industry of Hemodiaz Life Sciences Private Limited is Trade.

Is Hemodiaz Life Sciences Private Limited a listed company?

Hemodiaz Life Sciences Private Limited is unlisted.

What is the capital structure of Hemodiaz Life Sciences Private Limited?

The authorized capital of Hemodiaz Life Sciences Private Limited is ₹1.50 Cr, and the paid-up capital is ₹1.06 Cr.

What is the compliance status of Hemodiaz Life Sciences Private Limited?

The compliance status of Hemodiaz Life Sciences Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available